News
South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...
Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...
The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
FRIDAY, July 11, 2025 (HealthDay News) — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, ...
Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...
Explore more
Senate Republicans remain wary of eliminating the popular and successful global HIV/AIDS program PEPFAR, as they face down a ...
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Global HIV program a ...
Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results